Clinical Trials List
2024-12-01 - 2028-08-18
Phase II
Not yet recruiting5
Recruiting1
-
Trial Applicant
GILEAD SCIENCES HONG KONG LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳珈妤 Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 高育青 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- 王閔宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡宗翰 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 劉建廷 無
- 黃詩喻 Division of Hematology & Oncology
- 黃泰霖 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 李易濰 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 林偉哲 Division of Hematology & Oncology
- 林昶廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Pei-Jen Lou Division of Hematology & Oncology
- RUEY-LONG HONG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Hung-Ming Wang 無
- 曾滌庸 Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- Chi-Ting Liau 無
- Cheng-Lung Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Mu-Hsin Chang Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
120 participants